Virbac S.A.
VRBCF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $2,461 | $2,743 | $2,891 | $2,179 |
| - Cash | $139 | $150 | $157 | $176 |
| + Debt | $326 | $307 | $407 | $120 |
| Enterprise Value | $2,648 | $2,900 | $3,141 | $2,123 |
| Revenue | $738 | $694 | $703 | $636 |
| % Growth | 6.3% | -1.2% | 10.4% | – |
| Gross Profit | $497 | $455 | $483 | $410 |
| % Margin | 67.4% | 65.5% | 68.7% | 64.4% |
| EBITDA | $157 | $108 | $169 | $96 |
| % Margin | 21.2% | 15.5% | 24% | 15.1% |
| Net Income | $82 | $51 | $95 | $46 |
| % Margin | 11.2% | 7.3% | 13.5% | 7.3% |
| EPS Diluted | 9.83 | 6.05 | 11.29 | 5.53 |
| % Growth | 62.5% | -46.4% | 104.2% | – |
| Operating Cash Flow | $28 | $168 | $37 | $102 |
| Capital Expenditures | -$49 | -$59 | -$22 | -$26 |
| Free Cash Flow | -$21 | $109 | $15 | $76 |